BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 2188046)

  • 21. The biologic activity of mast cell granules. VII. The effect of anti-neutrophil antibody-induced neutropenia on rat cutaneous late phase reactions.
    Lemanske RF; Guthman DA; Kaliner M
    J Immunol; 1983 Aug; 131(2):929-33. PubMed ID: 6863936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.
    Solley GO; Gleich GJ; Jordon RE; Schroeter AL
    J Clin Invest; 1976 Aug; 58(2):408-20. PubMed ID: 783199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein.
    Page SM; Gleich GJ; Roebuck KA; Thomas LL
    Am J Respir Cell Mol Biol; 1999 Aug; 21(2):230-7. PubMed ID: 10423406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
    Yamazaki K; Suzuki K; Nakamura A; Sato S; Lindor KD; Batts KP; Tarara JE; Kephart GM; Kita H; Gleich GJ
    Hepatology; 1999 Jul; 30(1):71-8. PubMed ID: 10385641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine.
    Zweiman B; Atkins PC; Moskovitz A; von Allmen C; Ciliberti M; Grossman S
    J Allergy Clin Immunol; 1997 Sep; 100(3):341-7. PubMed ID: 9314346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis.
    Leiferman KM; Ackerman SJ; Sampson HA; Haugen HS; Venencie PY; Gleich GJ
    N Engl J Med; 1985 Aug; 313(5):282-5. PubMed ID: 3892296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release.
    Moy JN; Gleich GJ; Thomas LL
    J Immunol; 1990 Oct; 145(8):2626-32. PubMed ID: 2170521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine.
    Kephart GM; Gleich GJ; Connor DH; Gibson DW; Ackerman SJ
    Lab Invest; 1984 Jan; 50(1):51-61. PubMed ID: 6363816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neutrophil and chronic allergic inflammation. Immunochemical localization of neutrophil elastase.
    Fujisawa T; Kephart GM; Gray BH; Gleich GJ
    Am Rev Respir Dis; 1990 Mar; 141(3):689-97. PubMed ID: 2178530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
    Ackerman SJ; Loegering DA; Venge P; Olsson I; Harley JB; Fauci AS; Gleich GJ
    J Immunol; 1983 Dec; 131(6):2977-82. PubMed ID: 6644025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Eosinophil granule proteins (MBP, ECP, EPX/EDN, EPO)--a possible process of eosinophil activation and degranulation].
    Tsuda S; Miyasato M
    Nihon Rinsho; 1993 Mar; 51(3):613-9. PubMed ID: 8492433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic fungal sinusitis: an immunohistologic analysis.
    Khan DA; Cody DT; George TJ; Gleich GJ; Leiferman KM
    J Allergy Clin Immunol; 2000 Dec; 106(6):1096-101. PubMed ID: 11112892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin.
    Sedgwick JB; Vrtis RF; Jansen KJ; Kita H; Bartemes K; Busse WW
    J Allergy Clin Immunol; 2004 Sep; 114(3):568-74. PubMed ID: 15356558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.
    Borrego L; Maynard B; Peterson EA; George T; Iglesias L; Peters MS; Newman W; Gleich GJ; Leiferman KM
    Am J Pathol; 1996 Mar; 148(3):897-909. PubMed ID: 8774144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophilic vasculitis in connective tissue disease.
    Chen KR; Su WP; Pittelkow MR; Conn DL; George T; Leiferman KM
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):173-82. PubMed ID: 8708015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophil and neutrophil degranulation in ophthalmic lesions of Wegener's granulomatosis.
    Trocme SD; Bartley GB; Campbell RJ; Gleich GJ; Leiferman KM
    Arch Ophthalmol; 1991 Nov; 109(11):1585-9. PubMed ID: 1755742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of murine cutaneous late phase reaction requires both IgE antibodies and CD4 T cells.
    Sawada K; Nagai H; Basaki Y; Yamaya H; Ikizawa K; Watanabe M; Kojima M; Matsuura N; Kiniwa M
    Clin Exp Allergy; 1997 Feb; 27(2):225-31. PubMed ID: 9061224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.
    Hamann KJ; Barker RL; Loegering DA; Gleich GJ
    J Parasitol; 1987 Jun; 73(3):523-9. PubMed ID: 3598802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
    Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
    J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophil cationic protein- and eosinophil-derived neurotoxin/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis.
    Johansson O; Liang Y; Marcusson JA; Reimert CM
    Arch Dermatol Res; 2000 Aug; 292(8):371-8. PubMed ID: 10994770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.